GILD · News · 20260910N
Revenue Performance and Dividend
GILEAD SCIENCES, INC. · 2026-09-10 · Importance 29 · Surprise 22 · In source text
Gilead reported quarterly revenue growth of 10.6% year over year, exceeding analyst expectations. The revenue increase qualifies as material under the stated threshold for year-over-year changes above 10%. Gilead declared a quarterly dividend of $0.82 per share.
Key facts
- Gilead Sciences declared a quarterly dividend of $0.82. source
- Gilead Sciences has outperformed the market over the past 20 years with an average annual return of 11.56%. source
- An investment of $100 in Gilead Sciences stock 20 years ago would now be worth $893.61. source
- Gilead Sciences reported quarterly revenue growth of 10.6% year-over-year and beat analyst expectations. source
- Gilead Sciences currently has a market capitalization of $179.56 billion. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| liability | negative | committed | — | Gilead Sciences declared a quarterly dividend of $0.82. |
| cash | negative | committed | — | Gilead Sciences declared a quarterly dividend of $0.82. |